3118.1000 -14.70 (-0.47%)
NSE Sep 30, 2025 15:31 PM
Volume: 126.8K
 

3118.10
-0.47%
Emkay
We met DLPL’s MD Dr. Om Manchanda to gauge competitive intensity and its strategy to boost volumes. Meeting KTAs are: 1) DLPL is increasingly witnessing the ‘bundling’ phenomenon as doctors are recommending multiple tests to ascertain accurate prognosis.
Number of FII/FPI investors decreased from 382 to 358 in Jun 2025 qtr
More from Dr. Lal Pathlabs Ltd.
Recommended